EW
EW
US28176E1082
Edwards Lifesciences Corporatio
Loading chart...

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Latest News

Related stocks

GEHC
GEHC • United States
GE HealthCare Technologies Inc.
65.74 USD
29.9B USD 1Y -14.5%
BSX
BSX • United States
Boston Scientific Corporation
42.73 USD
61.93B USD 1Y -56.6%
SYK
SYK • United States
Stryker Corporation
277.33 USD
106.38B USD 1Y -26.2%
STE
STE • United States
STERIS plc (Ireland)
214.4 USD
20.9B USD 1Y -13%
DXCM
DXCM • United States
DexCom, Inc.
84.11 USD
31.74B USD 1Y +24.5%
PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
ZBH
ZBH • United States
Zimmer Biomet Holdings, Inc.
89.14 USD
17B USD 1Y -9.6%
ABT
ABT • United States
Abbott Laboratories
99.6 USD
173.48B USD 1Y -26.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
32.7% p.a.
Max Drawdown (5Y)
-54.3%
Sharpe Ratio (5Y)
-0.23
Beta Factor
0.86
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 50.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -54.3% in the extended horizon.
ende